NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,788.70₹0.00 (0.0%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
Loading market information…
NSE · ZIMLAB.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:52 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
ZIM Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 14.9% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ZIM Laboratories Limited’s forward annual dividend is ₹0.17 per share, paid annual. The forward yield is 0.12% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow ZIM Laboratories Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1984 and based in Nagpur, India, ZIM Laboratories Limited is a pharmaceutical company that develops, produces, and supplies both finished drug formulations and pre-formulation ingredients. Operating domestically and internationally, ZIM specializes in providing technology-driven drug delivery solutions and exclusive, non-infringing manufacturing processes for generic pharmaceuticals. These offerings span semi-finished and finished product categories, encompassing forms like granules, pellets, taste-masked powders, suspensions, tablets, capsules, and oral thin films. Their extensive product range caters to various therapeutic areas, including urology, gastroenterology, cardiology, and anticoagulation, alongside antibiotics, anti-infectives, NSAIDs/pain management, and vitamins and supplements.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,788.70₹0.00 (0.0%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
₹9,743.50₹0.00 (0.0%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
₹456.00-₹1.00 (-0.22%)
Bafna Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 4.99% below the high.
₹128.33₹0.00 (0.0%)
Valiant Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 9.23% below the high.
₹9.06+₹0.10 (+1.12%)
Gennex Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 46.67% below the high.
₹10.18-₹0.15 (-1.45%)
Nectar Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 54.55% below the high.
₹62.16-₹1.68 (-2.63%)
Brooks Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 46.41% below the high.
₹18.61-₹0.37 (-1.95%)
Medico Remedies Limited’s quoted price sits in the lower half of its reported 52-week range, 67.28% below the high.
